 | • レポートコード：MRC23Q37469 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の心臓病診断市場について調査・分析し、世界の心臓病診断市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（心電図、血液検査、血管造影、コンピュータ心電計）、用途別セグメント分析（病院、外来手術センター、診断センター）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GE Healthcare、Hitachi Corporation、Koninklijke Philips NV、Midmark Corporation,、F Hoffmann-La Roche Ltd、Schiller AG、Siemens Healthineers、Toshiba Corporation、Welch Allyn Inc、Astrazenca PLC.などが含まれています。 世界の心臓病診断市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、心臓病診断市場規模を推定する際に考慮しました。本レポートは、心臓病診断の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、心臓病診断に関するビジネス上の意思決定に役立てることを目的としています。 ・心臓病診断市場の概要 - 製品の定義 - 心臓病診断のタイプ別セグメント - 世界の心臓病診断市場規模：タイプ別分析（心電図、血液検査、血管造影、コンピュータ心電計） - 心臓病診断の用途別セグメント - 世界の心臓病診断市場規模：用途別分析（病院、外来手術センター、診断センター） - 世界の心臓病診断市場規模予測（2018年-2029年） - 心臓病診断の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 心臓病診断市場の競争状況およびトレンド ・心臓病診断の地域別市場規模 - 北米の心臓病診断市場規模（2018年-2029年） - アメリカの心臓病診断市場規模（2018年-2029年） - ヨーロッパの心臓病診断市場規模（2018年-2029年） - アジア太平洋の心臓病診断市場規模（2018年-2029年） - 中国の心臓病診断市場規模（2018年-2029年） - 日本の心臓病診断市場規模（2018年-2029年） - 韓国の心臓病診断市場規模（2018年-2029年） - インドの心臓病診断市場規模（2018年-2029年） - オーストラリアの心臓病診断市場規模（2018年-2029年） - 中南米の心臓病診断市場規模（2018年-2029年） - 中東・アフリカの心臓病診断市場規模（2018年-2029年） ・タイプ別セグメント：心電図、血液検査、血管造影、コンピュータ心電計 - 世界の心臓病診断のタイプ別販売量（2018年-2023年） - 世界の心臓病診断のタイプ別売上（2018年-2023年） - 世界の心臓病診断のタイプ別価格 ・用途別セグメント：病院、外来手術センター、診断センター - 世界の心臓病診断の用途別販売量（2018年-2023年） - 世界の心臓病診断の用途別売上（2018年-2023年） - 世界の心臓病診断の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 GE Healthcare、Hitachi Corporation、Koninklijke Philips NV、Midmark Corporation,、F Hoffmann-La Roche Ltd、Schiller AG、Siemens Healthineers、Toshiba Corporation、Welch Allyn Inc、Astrazenca PLC. ・産業チェーンと販売チャネルの分析 - 心臓病診断産業チェーン分析 - 心臓病診断の主要原材料 - 心臓病診断の販売チャネル - 心臓病診断のディストリビューター - 心臓病診断の主要顧客 ・心臓病診断市場ダイナミクス - 心臓病診断の業界動向 - 心臓病診断市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Heart Disease Diagnosis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Heart Disease Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Heart Disease Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Heart Disease Diagnosis include GE Healthcare, Hitachi Corporation, Koninklijke Philips NV, Midmark Corporation,, F Hoffmann-La Roche Ltd, Schiller AG, Siemens Healthineers, Toshiba Corporation and Welch Allyn Inc, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heart Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Disease Diagnosis.
The Heart Disease Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Heart Disease Diagnosis market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heart Disease Diagnosis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GE Healthcare
Hitachi Corporation
Koninklijke Philips NV
Midmark Corporation,
F Hoffmann-La Roche Ltd
Schiller AG
Siemens Healthineers
Toshiba Corporation
Welch Allyn Inc
Astrazenca PLC.
Segment by Type
ECG
Blood Test
Angiography
Computerized Cardiac Tomography
Segment by Application
Hospital
Ambulatory Surgery Center
Diagnostic Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heart Disease Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heart Disease Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Heart Disease Diagnosis Market Overview
1.1 Product Overview and Scope of Heart Disease Diagnosis
1.2 Heart Disease Diagnosis Segment by Type
1.2.1 Global Heart Disease Diagnosis Market Value Comparison by Type (2023-2029)
1.2.2 ECG
1.2.3 Blood Test
1.2.4 Angiography
1.2.5 Computerized Cardiac Tomography
1.3 Heart Disease Diagnosis Segment by Application
1.3.1 Global Heart Disease Diagnosis Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.3.4 Diagnostic Center
1.4 Global Heart Disease Diagnosis Market Size Estimates and Forecasts
1.4.1 Global Heart Disease Diagnosis Revenue 2018-2029
1.4.2 Global Heart Disease Diagnosis Sales 2018-2029
1.4.3 Global Heart Disease Diagnosis Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Heart Disease Diagnosis Market Competition by Manufacturers
2.1 Global Heart Disease Diagnosis Sales Market Share by Manufacturers (2018-2023)
2.2 Global Heart Disease Diagnosis Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Heart Disease Diagnosis Average Price by Manufacturers (2018-2023)
2.4 Global Heart Disease Diagnosis Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Heart Disease Diagnosis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heart Disease Diagnosis, Product Type & Application
2.7 Heart Disease Diagnosis Market Competitive Situation and Trends
2.7.1 Heart Disease Diagnosis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Heart Disease Diagnosis Players Market Share by Revenue
2.7.3 Global Heart Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heart Disease Diagnosis Retrospective Market Scenario by Region
3.1 Global Heart Disease Diagnosis Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Heart Disease Diagnosis Global Heart Disease Diagnosis Sales by Region: 2018-2029
3.2.1 Global Heart Disease Diagnosis Sales by Region: 2018-2023
3.2.2 Global Heart Disease Diagnosis Sales by Region: 2024-2029
3.3 Global Heart Disease Diagnosis Global Heart Disease Diagnosis Revenue by Region: 2018-2029
3.3.1 Global Heart Disease Diagnosis Revenue by Region: 2018-2023
3.3.2 Global Heart Disease Diagnosis Revenue by Region: 2024-2029
3.4 North America Heart Disease Diagnosis Market Facts & Figures by Country
3.4.1 North America Heart Disease Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Heart Disease Diagnosis Sales by Country (2018-2029)
3.4.3 North America Heart Disease Diagnosis Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Heart Disease Diagnosis Market Facts & Figures by Country
3.5.1 Europe Heart Disease Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Heart Disease Diagnosis Sales by Country (2018-2029)
3.5.3 Europe Heart Disease Diagnosis Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heart Disease Diagnosis Market Facts & Figures by Country
3.6.1 Asia Pacific Heart Disease Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Heart Disease Diagnosis Sales by Country (2018-2029)
3.6.3 Asia Pacific Heart Disease Diagnosis Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Heart Disease Diagnosis Market Facts & Figures by Country
3.7.1 Latin America Heart Disease Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Heart Disease Diagnosis Sales by Country (2018-2029)
3.7.3 Latin America Heart Disease Diagnosis Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heart Disease Diagnosis Market Facts & Figures by Country
3.8.1 Middle East and Africa Heart Disease Diagnosis Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Heart Disease Diagnosis Sales by Country (2018-2029)
3.8.3 Middle East and Africa Heart Disease Diagnosis Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Heart Disease Diagnosis Sales by Type (2018-2029)
4.1.1 Global Heart Disease Diagnosis Sales by Type (2018-2023)
4.1.2 Global Heart Disease Diagnosis Sales by Type (2024-2029)
4.1.3 Global Heart Disease Diagnosis Sales Market Share by Type (2018-2029)
4.2 Global Heart Disease Diagnosis Revenue by Type (2018-2029)
4.2.1 Global Heart Disease Diagnosis Revenue by Type (2018-2023)
4.2.2 Global Heart Disease Diagnosis Revenue by Type (2024-2029)
4.2.3 Global Heart Disease Diagnosis Revenue Market Share by Type (2018-2029)
4.3 Global Heart Disease Diagnosis Price by Type (2018-2029)
5 Segment by Application
5.1 Global Heart Disease Diagnosis Sales by Application (2018-2029)
5.1.1 Global Heart Disease Diagnosis Sales by Application (2018-2023)
5.1.2 Global Heart Disease Diagnosis Sales by Application (2024-2029)
5.1.3 Global Heart Disease Diagnosis Sales Market Share by Application (2018-2029)
5.2 Global Heart Disease Diagnosis Revenue by Application (2018-2029)
5.2.1 Global Heart Disease Diagnosis Revenue by Application (2018-2023)
5.2.2 Global Heart Disease Diagnosis Revenue by Application (2024-2029)
5.2.3 Global Heart Disease Diagnosis Revenue Market Share by Application (2018-2029)
5.3 Global Heart Disease Diagnosis Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Heart Disease Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GE Healthcare Heart Disease Diagnosis Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Hitachi Corporation
6.2.1 Hitachi Corporation Corporation Information
6.2.2 Hitachi Corporation Description and Business Overview
6.2.3 Hitachi Corporation Heart Disease Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Hitachi Corporation Heart Disease Diagnosis Product Portfolio
6.2.5 Hitachi Corporation Recent Developments/Updates
6.3 Koninklijke Philips NV
6.3.1 Koninklijke Philips NV Corporation Information
6.3.2 Koninklijke Philips NV Description and Business Overview
6.3.3 Koninklijke Philips NV Heart Disease Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Koninklijke Philips NV Heart Disease Diagnosis Product Portfolio
6.3.5 Koninklijke Philips NV Recent Developments/Updates
6.4 Midmark Corporation,
6.4.1 Midmark Corporation, Corporation Information
6.4.2 Midmark Corporation, Description and Business Overview
6.4.3 Midmark Corporation, Heart Disease Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Midmark Corporation, Heart Disease Diagnosis Product Portfolio
6.4.5 Midmark Corporation, Recent Developments/Updates
6.5 F Hoffmann-La Roche Ltd
6.5.1 F Hoffmann-La Roche Ltd Corporation Information
6.5.2 F Hoffmann-La Roche Ltd Description and Business Overview
6.5.3 F Hoffmann-La Roche Ltd Heart Disease Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.5.4 F Hoffmann-La Roche Ltd Heart Disease Diagnosis Product Portfolio
6.5.5 F Hoffmann-La Roche Ltd Recent Developments/Updates
6.6 Schiller AG
6.6.1 Schiller AG Corporation Information
6.6.2 Schiller AG Description and Business Overview
6.6.3 Schiller AG Heart Disease Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Schiller AG Heart Disease Diagnosis Product Portfolio
6.6.5 Schiller AG Recent Developments/Updates
6.7 Siemens Healthineers
6.6.1 Siemens Healthineers Corporation Information
6.6.2 Siemens Healthineers Description and Business Overview
6.6.3 Siemens Healthineers Heart Disease Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Siemens Healthineers Heart Disease Diagnosis Product Portfolio
6.7.5 Siemens Healthineers Recent Developments/Updates
6.8 Toshiba Corporation
6.8.1 Toshiba Corporation Corporation Information
6.8.2 Toshiba Corporation Description and Business Overview
6.8.3 Toshiba Corporation Heart Disease Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Toshiba Corporation Heart Disease Diagnosis Product Portfolio
6.8.5 Toshiba Corporation Recent Developments/Updates
6.9 Welch Allyn Inc
6.9.1 Welch Allyn Inc Corporation Information
6.9.2 Welch Allyn Inc Description and Business Overview
6.9.3 Welch Allyn Inc Heart Disease Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Welch Allyn Inc Heart Disease Diagnosis Product Portfolio
6.9.5 Welch Allyn Inc Recent Developments/Updates
6.10 Astrazenca PLC.
6.10.1 Astrazenca PLC. Corporation Information
6.10.2 Astrazenca PLC. Description and Business Overview
6.10.3 Astrazenca PLC. Heart Disease Diagnosis Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Astrazenca PLC. Heart Disease Diagnosis Product Portfolio
6.10.5 Astrazenca PLC. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heart Disease Diagnosis Industry Chain Analysis
7.2 Heart Disease Diagnosis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heart Disease Diagnosis Production Mode & Process
7.4 Heart Disease Diagnosis Sales and Marketing
7.4.1 Heart Disease Diagnosis Sales Channels
7.4.2 Heart Disease Diagnosis Distributors
7.5 Heart Disease Diagnosis Customers
8 Heart Disease Diagnosis Market Dynamics
8.1 Heart Disease Diagnosis Industry Trends
8.2 Heart Disease Diagnosis Market Drivers
8.3 Heart Disease Diagnosis Market Challenges
8.4 Heart Disease Diagnosis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer